Home » Topics » BioWorld Science

BioWorld Science
RSS

AMP-CpG-adjuvanted vaccine confers potent immunity against SARS-CoV-2 infection

Sep. 23, 2021

Oncolytic viruses target GSCs with specific p53 deregulations for personalized glioblastoma therapy

Sep. 23, 2021

Inhaled antibodies brought to SARS-CoV fight

Sep. 22, 2021

Synthetic queuine STL-101 shows neuroprotective potential

Sep. 22, 2021

Mosaic licenses rights to novel vaccine candidates from UC San Diego

Sep. 22, 2021

Novel OSBPL7-targeting compounds show therapeutic efficacy in models of renal disease

Sep. 22, 2021

SNP in the CBS gene tied to overall survival in patients with NSCLC

Sep. 22, 2021

Theragnostics and AAA to jointly develop Ga-68 one-step PET radiopharmaceuticals

Sep. 22, 2021

CMTA and Addex collaborate to investigate GABA-B PAMs for CMT1A

Sep. 22, 2021

Clearmind and Hebrew University partner on novel psychedelics

Sep. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...